Published in J Biol Chem on January 03, 2011
Remarkable stabilization of plasminogen activator inhibitor 1 in a "molecular sandwich" complex. Biochemistry (2013) 0.84
Characterization of a small molecule inhibitor of plasminogen activator inhibitor type 1 that accelerates the transition into the latent conformation. J Biol Chem (2012) 0.81
Inhibition of PAI-1 antiproteolytic activity against tPA by RNA aptamers. Nucleic Acid Ther (2014) 0.79
Contribution of conserved lysine residues in the alpha2-antiplasmin C terminus to plasmin binding and inhibition. J Biol Chem (2011) 0.79
A cyclic peptidic serine protease inhibitor: increasing affinity by increasing peptide flexibility. PLoS One (2014) 0.78
Crystal Structure of the Michaelis Complex between Tissue-type Plasminogen Activator and Plasminogen Activators Inhibitor-1. J Biol Chem (2015) 0.78
Distinct encounter complexes of PAI-1 with plasminogen activators and vitronectin revealed by changes in the conformation and dynamics of the reactive center loop. Protein Sci (2015) 0.75
Astragalus and Paeoniae Radix Rubra extract (APE) inhibits hepatic stellate cell activation by modulating transforming growth factor-β/Smad pathway. Mol Med Rep (2014) 0.75
Single fluorescence probes along the reactive center loop reveal site-specific changes during the latency transition of PAI-1. Protein Sci (2015) 0.75
Structural basis of specific inhibition of tissue-type plasminogen activator by plasminogen activators inhibitor-1. Data Brief (2016) 0.75
A specific plasminogen activator inhibitor-1 antagonist derived from inactivated urokinase. J Cell Mol Med (2016) 0.75
Urokinase-type plasminogen activator-like proteases in teleosts lack genuine receptor-binding epidermal growth factor-like domains. J Biol Chem (2012) 0.75
Characterization of the Annonaceous acetogenin, annonacinone, a natural product inhibitor of plasminogen activator inhibitor-1. Sci Rep (2016) 0.75
Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr (2004) 227.01
Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr (1997) 137.43
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol (2007) 14.29
Main-chain bond lengths and bond angles in protein structures. J Mol Biol (1993) 9.80
uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol (2002) 6.24
The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer (1997) 5.01
The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol Life Sci (2000) 3.91
Structural basis of latency in plasminogen activator inhibitor-1. Nature (1992) 2.33
Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin. Nat Struct Mol Biol (2004) 2.26
The urokinase plasminogen activator system: a target for anti-cancer therapy. Curr Cancer Drug Targets (2009) 1.87
How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration. Nat Struct Biol (2003) 1.76
Molecular evolution of plasminogen activator inhibitor-1 functional stability. EMBO J (1995) 1.73
uPA and uPAR in fibrinolysis, immunity and pathology. Trends Immunol (2004) 1.71
The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent. FASEB J (2002) 1.70
Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes. EMBO J (1997) 1.64
Serpin-resistant mutants of human tissue-type plasminogen activator. Nature (1989) 1.61
Antithrombin-S195A factor Xa-heparin structure reveals the allosteric mechanism of antithrombin activation. EMBO J (2006) 1.59
The urokinase plasminogen activator system: a rich source of tumour markers for the individualised management of patients with cancer. Clin Biochem (2004) 1.46
Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1. Cancer Res (2000) 1.46
Urokinase plasminogen activator and its inhibitor, PAI-1, as prognostic markers in breast cancer: from pilot to level 1 evidence studies. Clin Chem (2002) 1.44
The active conformation of plasminogen activator inhibitor 1, a target for drugs to control fibrinolysis and cell adhesion. Structure (1999) 1.40
Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer. Int J Cancer (1995) 1.35
Structure-function relationships in the interaction between the urokinase-type plasminogen activator and its receptor. Curr Pharm Des (2003) 1.35
The structure of a Michaelis serpin-protease complex. Nat Struct Biol (2001) 1.27
Resolution of Michaelis complex, acylation, and conformational change steps in the reactions of the serpin, plasminogen activator inhibitor-1, with tissue plasminogen activator and trypsin. Biochemistry (2001) 1.21
Mechanisms contributing to the conformational and functional flexibility of plasminogen activator inhibitor-1. Nat Struct Biol (1995) 1.20
Serpins flex their muscle: II. Structural insights into target peptidase recognition, polymerization, and transport functions. J Biol Chem (2010) 1.14
Structures of active and latent PAI-1: a possible stabilizing role for chloride ions. Biochemistry (2000) 1.13
Saturation mutagenesis of the plasminogen activator inhibitor-1 reactive center. J Biol Chem (1992) 1.05
Plasminogen activator inhibitor 1. Structure of the native serpin, comparison to its other conformers and implications for serpin inactivation. J Mol Biol (2000) 1.04
Conversion of the active to latent plasminogen activator inhibitor from human endothelial cells. Blood (1987) 1.03
Polymerization of plasminogen activator inhibitor-1. J Biol Chem (2000) 1.00
A regulatory hydrophobic area in the flexible joint region of plasminogen activator inhibitor-1, defined with fluorescent activity-neutralizing ligands. Ligand-induced serpin polymerization. J Biol Chem (2001) 0.97
The vitronectin binding area of plasminogen activator inhibitor-1, mapped by mutagenesis and protection against an inactivating organochemical ligand. FEBS Lett (2002) 0.96
Identification of novel binding interactions in the development of potent, selective 2-naphthamidine inhibitors of urokinase. Synthesis, structural analysis, and SAR of N-phenyl amide 6-substitution. J Med Chem (2004) 0.95
The crystal structure of the catalytic domain of human urokinase-type plasminogen activator. Structure (1995) 0.94
The contribution of the exosite residues of plasminogen activator inhibitor-1 to proteinase inhibition. J Biol Chem (2003) 0.93
Interfering with the inhibitory mechanism of serpins: crystal structure of a complex formed between cleaved plasminogen activator inhibitor type 1 and a reactive-centre loop peptide. Structure (1998) 0.90
On the target specificity of plasminogen activator inhibitor 1: the role of heparin, vitronectin, and the reactive site. Blood (1991) 0.90
Structural basis of specificity of a peptidyl urokinase inhibitor, upain-1. J Struct Biol (2007) 0.88
High-resolution structure of the stable plasminogen activator inhibitor type-1 variant 14-1B in its proteinase-cleaved form: a new tool for detailed interaction studies and modeling. Protein Sci (2008) 0.87
Mutational analysis of plasminogen activator inhibitor-1. Eur J Biochem (2003) 0.87
The acid stabilization of plasminogen activator inhibitor-1 depends on protonation of a single group that affects loop insertion into beta-sheet A. J Biol Chem (1995) 0.85
High quality structure of cleaved PAI-1-stab. J Struct Biol (2008) 0.79
Genome-wide association study of 107 phenotypes in Arabidopsis thaliana inbred lines. Nature (2010) 10.66
Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science (2013) 4.94
Mechanisms of thrombus formation. N Engl J Med (2008) 4.67
Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat Med (2002) 4.54
Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med (2003) 3.61
Retrograde light-guided laryngoscopy for tracheal intubation: clinical practice and comparison with conventional direct laryngoscopy. Anesthesiology (2013) 3.22
A large number of novel coding small open reading frames in the intergenic regions of the Arabidopsis thaliana genome are transcribed and/or under purifying selection. Genome Res (2007) 2.72
Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain. Proc Natl Acad Sci U S A (2002) 2.60
Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility. Nature (2013) 2.52
Interaction with vesicle luminal protachykinin regulates surface expression of delta-opioid receptors and opioid analgesia. Cell (2005) 2.52
Facilitation of μ-opioid receptor activity by preventing δ-opioid receptor-mediated codegradation. Neuron (2011) 2.42
Thrombus formation in vivo. J Clin Invest (2005) 2.38
Autophagy negatively regulates Wnt signalling by promoting Dishevelled degradation. Nat Cell Biol (2010) 2.37
A critical role for extracellular protein disulfide isomerase during thrombus formation in mice. J Clin Invest (2008) 2.26
Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood (2004) 2.16
Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaffinity separation strategy. Mol Cell Proteomics (2008) 2.08
Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo. Blood (2006) 2.06
An infectious disease of ducks caused by a newly emerged Tembusu virus strain in mainland China. Virology (2011) 2.05
Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules. Cell Res (2010) 2.04
Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res (2009) 2.04
The draft genome of the parasitic nematode Trichinella spiralis. Nat Genet (2011) 2.03
Intertransversalis fascia approach in urologic laparoscopic operations. Arch Surg (2012) 2.03
Haploidentical transplantation using T cell replete peripheral blood stem cells and myeloablative conditioning in patients with high-risk hematologic malignancies who lack conventional donors is well tolerated and produces excellent relapse-free survival: results of a prospective phase II trial. Biol Blood Marrow Transplant (2012) 1.97
Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis. Proc Natl Acad Sci U S A (2006) 1.95
Crystal structure of human factor VIII: implications for the formation of the factor IXa-factor VIIIa complex. Structure (2008) 1.93
Three immunomarker support vector machines-based prognostic classifiers for stage IB non-small-cell lung cancer. J Clin Oncol (2009) 1.91
Mixed infection and the genesis of influenza virus diversity. J Virol (2009) 1.88
A methyl transferase links the circadian clock to the regulation of alternative splicing. Nature (2010) 1.88
Structure of human urokinase plasminogen activator in complex with its receptor. Science (2006) 1.84
Thrombin-initiated platelet activation in vivo is vWF independent during thrombus formation in a laser injury model. J Clin Invest (2007) 1.76
The risk factors for hypoxemia in children younger than 5 years old undergoing rigid bronchoscopy for foreign body removal. Anesth Analg (2009) 1.75
Inhibition of inflammatory pain by activating B-type natriuretic peptide signal pathway in nociceptive sensory neurons. J Neurosci (2010) 1.71
Coexpression of delta- and mu-opioid receptors in nociceptive sensory neurons. Proc Natl Acad Sci U S A (2010) 1.70
β₂-Glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model. Blood (2011) 1.69
Structural basis of membrane binding by Gla domains of vitamin K-dependent proteins. Nat Struct Biol (2003) 1.68
Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev (2012) 1.68
Size-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivo. ACS Nano (2012) 1.62
LncRNAs expression signatures of renal clear cell carcinoma revealed by microarray. PLoS One (2012) 1.59
Activation of delta opioid receptors induces receptor insertion and neuropeptide secretion. Neuron (2003) 1.57
Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo. Cancer Lett (2011) 1.55
Platelet PECAM-1 inhibits thrombus formation in vivo. Blood (2005) 1.53
Quantitative chemical imaging with multiplex stimulated Raman scattering microscopy. J Am Chem Soc (2012) 1.51
Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin. J Clin Invest (2012) 1.51
Temporary balloon occlusion of inferior vena cava in resection of renal tumor with vena cava thrombus extension. Urology (2009) 1.49
Applying narrow-band imaging in complement with white-light imaging cystoscopy in the detection of urothelial carcinoma of the bladder. Urol Oncol (2011) 1.48
PSGL-1 participates in E-selectin-mediated progenitor homing to bone marrow: evidence for cooperation between E-selectin ligands and alpha4 integrin. Blood (2003) 1.46
Leukocyte-versus microparticle-mediated tissue factor transfer during arteriolar thrombus development. J Leukoc Biol (2005) 1.46
Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents. J Clin Invest (2012) 1.45
Endothelium-derived but not platelet-derived protein disulfide isomerase is required for thrombus formation in vivo. Blood (2010) 1.43
The effect of carvedilol treatment on chronic heart failure in pediatric patients with dilated cardiomyopathy: a prospective, randomized-controlled study. Pediatr Cardiol (2012) 1.42
The products of the thermal decomposition of CH3CHO. J Chem Phys (2011) 1.41
Sensory reconstruction of a finger pulp defect using a dorsal homodigital island flap. Plast Reconstr Surg (2012) 1.40
Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking. Proc Natl Acad Sci U S A (2009) 1.40
Evolving renorrhaphy technique for retroperitoneal laparoscopic partial nephrectomy: single-surgeon series. Int J Urol (2014) 1.40
Serum 25-hydroxyvitamin D concentrations and prevalence estimates of hypovitaminosis D in the U.S. population based on assay-adjusted data. J Nutr (2012) 1.40
Outcomes and complications related to the management of Bosniak cystic renal lesions. AJR Am J Roentgenol (2015) 1.40
Single-cell imaging of retinal ganglion cell apoptosis with a cell-penetrating, activatable peptide probe in an in vivo glaucoma model. Proc Natl Acad Sci U S A (2009) 1.40
Transurethral partial cystectomy with continuous wave laser for bladder carcinoma. J Urol (2009) 1.39
Characterization of bundled and individual triple-walled carbon nanotubes by resonant Raman spectroscopy. ACS Nano (2013) 1.38
Role of P-selectin and PSGL-1 in coagulation and thrombosis. Thromb Haemost (2004) 1.36
PTP-1B is an essential positive regulator of platelet integrin signaling. J Cell Biol (2005) 1.34
An improved cell-penetrating, caspase-activatable, near-infrared fluorescent peptide for apoptosis imaging. Bioconjug Chem (2009) 1.34
Novel role of vitamin k in preventing oxidative injury to developing oligodendrocytes and neurons. J Neurosci (2003) 1.33
Effect of axial force on the performance of micromachined vibratory rate gyroscopes. Sensors (Basel) (2010) 1.32
Genome-wide variation of cytosine modifications between European and African populations and the implications for complex traits. Genetics (2013) 1.31
Hyperspectral imaging with stimulated Raman scattering by chirped femtosecond lasers. J Phys Chem B (2013) 1.30
Structure and mechanism of the uracil transporter UraA. Nature (2011) 1.29
Functional gene diversity of soil microbial communities from five oil-contaminated fields in China. ISME J (2010) 1.28
Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T. Radiology (2010) 1.26
Protein disulfide isomerase capture during thrombus formation in vivo depends on the presence of β3 integrins. Blood (2012) 1.26
Differential miRNA expression profiles in bladder urothelial carcinomas. Asian Pac J Cancer Prev (2010) 1.26